eFFECTOR Therapeutics, Inc. (EFTR)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 20.54 Million USD | -29.35% |
| 2022 | 29.07 Million USD | -46.21% |
| 2021 | 54.05 Million USD | 223.61% |
| 2020 | 16.7 Million USD | 227.85% |
| 2019 | 5.09 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 27.13 Million USD | 32.06% |
| 2023 Q3 | 20.16 Million USD | -25.02% |
| 2023 Q1 | 21.92 Million USD | -24.59% |
| 2023 FY | 20.54 Million USD | -29.35% |
| 2023 Q2 | 26.88 Million USD | 22.62% |
| 2023 Q4 | 20.54 Million USD | 1.9% |
| 2022 FY | 29.07 Million USD | -46.21% |
| 2022 Q4 | 29.07 Million USD | -20.67% |
| 2022 Q3 | 36.65 Million USD | -15.69% |
| 2022 Q2 | 43.47 Million USD | -12.17% |
| 2022 Q1 | 49.49 Million USD | -8.44% |
| 2021 Q1 | 17.15 Million USD | 2.67% |
| 2021 FY | 54.05 Million USD | 223.61% |
| 2021 Q4 | 54.05 Million USD | -9.81% |
| 2021 Q3 | 59.93 Million USD | 319.69% |
| 2021 Q2 | 14.28 Million USD | -16.73% |
| 2020 Q1 | - USD | 0.0% |
| 2020 FY | 16.7 Million USD | 227.85% |
| 2020 Q4 | 16.7 Million USD | 0.0% |
| 2019 FY | 5.09 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| America Great Health | 299.12 Thousand USD | -6767.94% |
| Ampio Pharmaceuticals, Inc. | 5.73 Million USD | -258.159% |
| Aridis Pharmaceuticals, Inc. | 14.69 Million USD | -39.803% |
| Biora Therapeutics, Inc. | 31.21 Million USD | 34.185% |
| Bio-Path Holdings, Inc. | 3.22 Million USD | -538.012% |
| Better Therapeutics, Inc. | 22.94 Million USD | 10.456% |
| Calithera Biosciences, Inc. | 28.67 Million USD | 28.358% |
| Comera Life Sciences Holdings, Inc. | 3.72 Million USD | -451.204% |
| Gene Biotherapeutics, Inc. | - USD | -Infinity% |
| Eloxx Pharmaceuticals, Inc. | 21.12 Million USD | 2.741% |
| Evelo Biosciences, Inc. | 64.44 Million USD | 68.12% |
| Evolutionary Genomics, Inc. | 2.35 Million USD | -772.835% |
| Finch Therapeutics Group, Inc. | 70.99 Million USD | 71.064% |
| Galera Therapeutics, Inc. | 26.14 Million USD | 21.411% |
| Innovation1 Biotech Inc. | 75.99 Thousand USD | -26934.069% |
| Kiromic BioPharma, Inc. | 12.16 Million USD | -68.822% |
| Molecular Templates, Inc. | 35.38 Million USD | 41.938% |
| Navidea Biopharmaceuticals, Inc. | 4.37 Million USD | -369.942% |
| NexImmune, Inc. | 8.59 Million USD | -139.052% |
| Orgenesis Inc. | 14.55 Million USD | -41.176% |
| Panbela Therapeutics, Inc. | 11.8 Million USD | -74.072% |
| Point of Care Nano-Technology, Inc. | 124.64 Thousand USD | -16382.273% |
| PaxMedica, Inc. Common Stock | 5.68 Million USD | -261.664% |
| Scopus BioPharma Inc. | 392.26 Thousand USD | -5137.276% |
| Sorrento Therapeutics, Inc. | 472.84 Million USD | 95.655% |
| Statera Biopharma, Inc. | 21.16 Million USD | 2.956% |
| TRACON Pharmaceuticals, Inc. | 10.1 Million USD | -103.305% |
| Trevena, Inc. | 40.6 Million USD | 49.405% |
| Vaxxinity, Inc. | 44.35 Million USD | 53.681% |
| Vaccinex, Inc. | 3.63 Million USD | -465.795% |
| Vicapsys Life Sciences, Inc. | 39.65 Thousand USD | -51705.528% |
| Viracta Therapeutics, Inc. | 56.69 Million USD | 63.762% |
| ZIVO Bioscience, Inc. | 555.71 Thousand USD | -3596.859% |